Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Defibrillator: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering.
The rising prevalence of cardiovascular diseases (CVDs) due to changed lifestyles has fueled the market for defibrillators. Lifestyle diseases such as hypertension, obesity, type 2 diabetes, and dyslipidemia are the major risk factors for CVD. CVD prevalence is also increasing due to the growing geriatric population, so the incidence of heart disease is expected to increase.
During the last few years, significant improvements have been made in defibrillators. The development of subcutaneous implantable cardioverter-defibrillator (S-ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) is expected to drive market growth during the forecast period. High growth opportunities for defibrillators in emerging markets have also fueled the demand.
The growing prevalence of CVDs will be the key factor of market growth during the forecast period. Secondly, technological advancements such as the introduction of new devices with simplified implantation technology, smaller size, and reduced or eliminated leads are also driving the market growth.
In addition, the growing geriatric population worldwide, growing healthcare expenditures especially in the Asia-Pacific region, government initiatives, and support for the use of AEDs in public places will contribute to the growth of the market during the forecast period. The major players in the market are Medtronic plc, Abbott Laboratories, Philips Medical Corp., Stryker, Boston Scientific Corp., and Zoll Corp.
This report segments the defibrillators market by type, application, end user, and region. Based on the type, the market is segmented into implantable cardioverter defibrillators and external cardioverter defibrillators. The implantable cardioverter defibrillators segment has the highest share in the market; leading products includes the Entrant HF CRT-D, Entrant ICD, Gallant ICD, and Quadra Assura MP CRT-D (all from Abbott Laboratories).
Some major AEDs are the HeartStart HS AED and HeartStart FRx AED (Philips); Propaq M, Propaq MD and X Series defibrillators from Asahi Kasei; Resonate family of CRT-Ds and Dynagen X4 CRT-D from Boston Scientific; Platinum Lifeline ARM from LivaNova; and A-16 AED by Mediana. Based on application, the implantable cardioverter defibrillators market is segmented into cardiac resynchronization therapy defibrillators (CRT-D), subcutaneous implantable cardioverter defibrillators (S-ICD), and transvenous cardioverter defibrillators (T-ICD), and the external defibrillators market is segmented into manual external defibrillators, automated external defibrillators and wearable cardioverter defibrillators. Based on end user, the market is segmented into hospitals, clinics and cardiac centers; public access and pre-hospital; and home care
Key Topics Covered:
Chapter 1 Market Outlook
1.1 Market Snapshot
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Defibrillators
3.2 Implantable Cardioverter Defibrillators (ICDs)
3.2.1 Transvenous or Traditional ICDs
3.2.2 Subcutaneous ICDs
3.2.3 Cardiac Resynchronization Therapy-Defibrillator
3.3 External Defibrillators
3.3.1 Manual External Defibrillators
3.3.2 Automated External Defibrillators (AEDs)
3.3.3 Wearable Cardioverter Defibrillators (WCDs)
3.4 Market Drivers
3.4.1 Increasing Prevalence of the Cardiac Disorders
3.4.2 Technological Advancements in Defibrillators
3.4.3 Growing Awareness and Government Initiatives
3.5 Market Barriers
3.5.1 Technical Issues in Implantable and Automated External Defibrillators
3.5.2 Lack of Training and Awareness
3.6 Market Opportunities
3.6.1 Rise in Demand for Defibrillators in Emerging Markets
3.6.2 Impact of COVID-19 Pandemic
Chapter 4 Market Breakdown by Type
4.1 Market by Type of Defibrillator
4.1.1 Market Overview
4.1.2 Market Revenue
4.1.3 Implantable Cardioverter Defibrillators
4.1.4 External Defibrillators
Chapter 5 Market Breakdown by End User
5.1 Overview
5.2 Hospitals, Clinics and Cardiac Centers
5.3 Public Access and Pre-hospital
5.4 Home Care
Chapter 6 Market Breakdown by Region
6.1 Introduction
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Rest of the World
Chapter 7 Competitive Landscape
7.1 Mergers, Acquisitions, and Collaborations
7.1.1 Recent Developments in the Market for Defibrillators
7.1.2 Defibrillator Market Shares
7.1.3 FDA approvals for Premarket AEDs in 2019, 2020 and 2021
7.1.4 Recent Product Recalls
Chapter 8 Company Profiles
Chapter 9 Project Scope and Methodology
9.1 Scope of Report
9.2 Methodology
9.3 Analyst's Credentials
9.4 Custom Research
9.5 Related Research Reports
Companies Mentioned
- Abbott Laboratories
- Asahi Kasei Corp.
- Biotronik Se & Co. Kg
- Boston Scientific Corp.
- Defibtech Llc
- Livanova
- Mediana
- Medtronic Plc
- Nihon Kohden Corp.
- Philips Medical Corp.
- Stryker Corp.
For more information about this report visit https://www.researchandmarkets.com/r/n8p56w
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
